Description
Septodont OraVerse Phentolamine Mesylate Injection 10 x 0.4 mg / 1.7 mL 99210
Features & benefits
OraVerse is the first and only local anesthesia reversal agent
In clinical trials, the median time to recovery of normal sensation in the upper lip was 50 minutes for OraVerse patients vs. 133 minutes for the control group and in the lower lip was 70 minutes for OraVerse patients vs. 155 minutes for the control.
In clinical trials, OraVerse patients were more quickly able to smile, speak, drink normally and minimize drooling.
Market research shows 88% of patients may be interested in receiving a product like OraVerse1.
Package Contents : 99210 – Box containing 1 blister of 10 x 1.7ml glass cartridges
